Need to include ASMD as a notified condition in the National Policy for rare diseases
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
WINLEVI works differently from any other topical acne treatment
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
The medical device sector is considered as one of the sunrise sectors in the country
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Subscribe To Our Newsletter & Stay Updated